Free tool
FAERS Monitor: Platinol-Aq
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 018057 or its brand name (Platinol-Aq, Cisplatin). Reports on generic versions are filed under their own applications.
Reports
79,029
Serious
76,537
97% of reports
Hospitalization
32,885
Death reported
15,097
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- off label use6,031
- nausea5,501
- neutropenia4,930
- disease progression4,706
- febrile neutropenia4,684
- vomiting4,613
- anaemia4,126
- thrombocytopenia3,876
- diarrhoea3,799
- pyrexia3,439
- malignant neoplasm progression3,368
- drug ineffective3,357
- myelosuppression2,846
- death2,772
- fatigue2,550
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 1,414 |
| 2005 | 1,699 |
| 2006 | 1,337 |
| 2007 | 1,579 |
| 2008 | 1,737 |
| 2009 | 1,914 |
| 2010 | 2,315 |
| 2011 | 2,826 |
| 2012 | 3,162 |
| 2013 | 2,276 |
| 2014 | 2,448 |
| 2015 | 3,410 |
| 2016 | 3,449 |
| 2017 | 3,770 |
| 2018 | 4,188 |
| 2019 | 4,520 |
| 2020 | 4,573 |
| 2021 | 4,631 |
| 2022 | 5,374 |
| 2023 | 6,288 |
| 2024 | 6,187 |
| 2025 | 5,818 |
| 2026 | 4,111 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,975,130 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| myelosuppressionSignal | 2,846 | 22.7 | 21.9 | 54,572 |
| febrile neutropeniaSignal | 4,684 | 20.1 | 19.6 | 79,437 |
| disease progressionSignal | 4,706 | 11.0 | 10.7 | 41,222 |
| neutropeniaSignal | 4,930 | 10.0 | 9.7 | 38,610 |
| thrombocytopeniaSignal | 3,876 | 9.5 | 9.2 | 28,675 |
| malignant neoplasm progressionSignal | 3,368 | 9.0 | 8.7 | 23,321 |
| anaemiaSignal | 4,126 | 5.9 | 5.7 | 16,426 |
| pyrexiaSignal | 3,439 | 2.7 | 2.6 | 3,589 |
| vomitingSignal | 4,613 | 2.6 | 2.6 | 4,707 |
| nausea | 5,501 | 1.9 | 1.8 | 2,239 |
| off label use | 6,031 | 1.8 | 1.8 | 2,391 |
| diarrhoea | 3,799 | 1.6 | 1.5 | 805 |
| fatigue | 2,550 | 0.9 | 0.8 | 50 |
| death | 2,772 | 0.9 | 0.8 | 70 |
| drug ineffective | 3,357 | 0.7 | 0.7 | 550 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.